Global Influenza Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 91

Published Date: 23 Mar 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Influenza Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Influenza Diagnostics size is estimated to be USD 2859.4 million in 2026 from USD 2259.1 million in 2020, with a change XX% between 2020 and 2021. The global Influenza Diagnostics market size is expected to grow at a CAGR of 6.1% for the next five years.

Market segmentation
Influenza Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    RIDT
    RT-PCR
    Cell Culture
    Others

Market segment by Application, can be divided into
    Hospitals
    POCT
    Others

Market segment by players, this report covers
    BD
    Abbott (Include Alere)
    Roche
    SIEMENS
    Analytik Jena
    Quidel
    Thermo Fisher
    Meridian Bioscience
    BioMerieux
    Sekisui Diagnostics
    Response Biomedical
    SA Scientific

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Influenza Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Influenza Diagnostics, with revenue, gross margin and global market share of Influenza Diagnostics from 2019 to 2021.
Chapter 3, the Influenza Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Influenza Diagnostics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Influenza Diagnostics research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Influenza Diagnostics
    1.2 Classification of Influenza Diagnostics by Type
        1.2.1 Overview: Global Influenza Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Influenza Diagnostics Revenue Market Share by Type in 2020
        1.2.3 RIDT
        1.2.4 RT-PCR
        1.2.5 Cell Culture
        1.2.6 Others
    1.3 Global Influenza Diagnostics Market by Application
        1.3.1 Overview: Global Influenza Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 POCT
        1.3.4 Others
    1.4 Global Influenza Diagnostics Market Size & Forecast
    1.5 Global Influenza Diagnostics Market Size and Forecast by Region
        1.5.1 Global Influenza Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Influenza Diagnostics Market Size by Region, (2016-2021)
        1.5.3 North America Influenza Diagnostics Market Size and Prospect (2016-2026)
        1.5.4 Europe Influenza Diagnostics Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Influenza Diagnostics Market Size and Prospect (2016-2026)
        1.5.6 South America Influenza Diagnostics Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Influenza Diagnostics Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Influenza Diagnostics Market Drivers
        1.6.2 Influenza Diagnostics Market Restraints
        1.6.3 Influenza Diagnostics Trends Analysis

2 Company Profiles
    2.1 BD
        2.1.1 BD Details
        2.1.2 BD Major Business
        2.1.3 BD Influenza Diagnostics Product and Solutions
        2.1.4 BD Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 BD Recent Developments and Future Plans
    2.2 Abbott (Include Alere)
        2.2.1 Abbott (Include Alere) Details
        2.2.2 Abbott (Include Alere) Major Business
        2.2.3 Abbott (Include Alere) Influenza Diagnostics Product and Solutions
        2.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Abbott (Include Alere) Recent Developments and Future Plans
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche Influenza Diagnostics Product and Solutions
        2.3.4 Roche Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Roche Recent Developments and Future Plans
    2.4 SIEMENS
        2.4.1 SIEMENS Details
        2.4.2 SIEMENS Major Business
        2.4.3 SIEMENS Influenza Diagnostics Product and Solutions
        2.4.4 SIEMENS Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 SIEMENS Recent Developments and Future Plans
    2.5 Analytik Jena
        2.5.1 Analytik Jena Details
        2.5.2 Analytik Jena Major Business
        2.5.3 Analytik Jena Influenza Diagnostics Product and Solutions
        2.5.4 Analytik Jena Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Analytik Jena Recent Developments and Future Plans
    2.6 Quidel
        2.6.1 Quidel Details
        2.6.2 Quidel Major Business
        2.6.3 Quidel Influenza Diagnostics Product and Solutions
        2.6.4 Quidel Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Quidel Recent Developments and Future Plans
    2.7 Thermo Fisher
        2.7.1 Thermo Fisher Details
        2.7.2 Thermo Fisher Major Business
        2.7.3 Thermo Fisher Influenza Diagnostics Product and Solutions
        2.7.4 Thermo Fisher Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Thermo Fisher Recent Developments and Future Plans
    2.8 Meridian Bioscience
        2.8.1 Meridian Bioscience Details
        2.8.2 Meridian Bioscience Major Business
        2.8.3 Meridian Bioscience Influenza Diagnostics Product and Solutions
        2.8.4 Meridian Bioscience Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Meridian Bioscience Recent Developments and Future Plans
    2.9 BioMerieux
        2.9.1 BioMerieux Details
        2.9.2 BioMerieux Major Business
        2.9.3 BioMerieux Influenza Diagnostics Product and Solutions
        2.9.4 BioMerieux Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 BioMerieux Recent Developments and Future Plans
    2.10 Sekisui Diagnostics
        2.10.1 Sekisui Diagnostics Details
        2.10.2 Sekisui Diagnostics Major Business
        2.10.3 Sekisui Diagnostics Influenza Diagnostics Product and Solutions
        2.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Sekisui Diagnostics Recent Developments and Future Plans
    2.11 Response Biomedical
        2.11.1 Response Biomedical Details
        2.11.2 Response Biomedical Major Business
        2.11.3 Response Biomedical Influenza Diagnostics Product and Solutions
        2.11.4 Response Biomedical Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Response Biomedical Recent Developments and Future Plans
    2.12 SA Scientific
        2.12.1 SA Scientific Details
        2.12.2 SA Scientific Major Business
        2.12.3 SA Scientific Influenza Diagnostics Product and Solutions
        2.12.4 SA Scientific Influenza Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 SA Scientific Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Influenza Diagnostics Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Influenza Diagnostics Players Market Share
        3.2.2 Top 10 Influenza Diagnostics Players Market Share
        3.2.3 Market Competition Trend
    3.3 Influenza Diagnostics Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Influenza Diagnostics Revenue and Market Share by Type (2016-2021)
    4.2 Global Influenza Diagnostics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Influenza Diagnostics Revenue Market Share by Application (2016-2021)
    5.2 Influenza Diagnostics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Influenza Diagnostics Revenue by Type (2016-2026)
    6.2 North America Influenza Diagnostics Revenue by Application (2016-2026)
    6.3 North America Influenza Diagnostics Market Size by Country
        6.3.1 North America Influenza Diagnostics Revenue by Country (2016-2026)
        6.3.2 United States Influenza Diagnostics Market Size and Forecast (2016-2026)
        6.3.3 Canada Influenza Diagnostics Market Size and Forecast (2016-2026)
        6.3.4 Mexico Influenza Diagnostics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Influenza Diagnostics Revenue by Type (2016-2026)
    7.2 Europe Influenza Diagnostics Revenue by Application (2016-2026)
    7.3 Europe Influenza Diagnostics Market Size by Country
        7.3.1 Europe Influenza Diagnostics Revenue by Country (2016-2026)
        7.3.2 Germany Influenza Diagnostics Market Size and Forecast (2016-2026)
        7.3.3 France Influenza Diagnostics Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Influenza Diagnostics Market Size and Forecast (2016-2026)
        7.3.5 Russia Influenza Diagnostics Market Size and Forecast (2016-2026)
        7.3.6 Italy Influenza Diagnostics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Influenza Diagnostics Revenue by Type (2016-2026)
    8.2 Asia-Pacific Influenza Diagnostics Revenue by Application (2016-2026)
    8.3 Asia-Pacific Influenza Diagnostics Market Size by Region
        8.3.1 Asia-Pacific Influenza Diagnostics Revenue by Region (2016-2026)
        8.3.2 China Influenza Diagnostics Market Size and Forecast (2016-2026)
        8.3.3 Japan Influenza Diagnostics Market Size and Forecast (2016-2026)
        8.3.4 South Korea Influenza Diagnostics Market Size and Forecast (2016-2026)
        8.3.5 India Influenza Diagnostics Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Influenza Diagnostics Market Size and Forecast (2016-2026)
        8.3.7 Australia Influenza Diagnostics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Influenza Diagnostics Revenue by Type (2016-2026)
    9.2 South America Influenza Diagnostics Revenue by Application (2016-2026)
    9.3 South America Influenza Diagnostics Market Size by Country
        9.3.1 South America Influenza Diagnostics Revenue by Country (2016-2026)
        9.3.2 Brazil Influenza Diagnostics Market Size and Forecast (2016-2026)
        9.3.3 Argentina Influenza Diagnostics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Influenza Diagnostics Revenue by Type (2016-2026)
    10.2 Middle East & Africa Influenza Diagnostics Revenue by Application (2016-2026)
    10.3 Middle East & Africa Influenza Diagnostics Market Size by Country
        10.3.1 Middle East & Africa Influenza Diagnostics Revenue by Country (2016-2026)
        10.3.2 Turkey Influenza Diagnostics Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Influenza Diagnostics Market Size and Forecast (2016-2026)
        10.3.4 UAE Influenza Diagnostics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Influenza Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Influenza Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Influenza Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Influenza Diagnostics Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Influenza Diagnostics Revenue Market Share by Region (2021-2026)
    Table 6. BD Corporate Information, Head Office, and Major Competitors
    Table 7. BD Major Business
    Table 8. BD Influenza Diagnostics Product and Solutions
    Table 9. BD Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Abbott (Include Alere) Corporate Information, Head Office, and Major Competitors
    Table 11. Abbott (Include Alere) Major Business
    Table 12. Abbott (Include Alere) Influenza Diagnostics Product and Solutions
    Table 13. Abbott (Include Alere) Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Roche Corporate Information, Head Office, and Major Competitors
    Table 15. Roche Major Business
    Table 16. Roche Influenza Diagnostics Product and Solutions
    Table 17. Roche Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. SIEMENS Corporate Information, Head Office, and Major Competitors
    Table 19. SIEMENS Major Business
    Table 20. SIEMENS Influenza Diagnostics Product and Solutions
    Table 21. SIEMENS Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Analytik Jena Corporate Information, Head Office, and Major Competitors
    Table 23. Analytik Jena Major Business
    Table 24. Analytik Jena Influenza Diagnostics Product and Solutions
    Table 25. Analytik Jena Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Quidel Corporate Information, Head Office, and Major Competitors
    Table 27. Quidel Major Business
    Table 28. Quidel Influenza Diagnostics Product and Solutions
    Table 29. Quidel Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Thermo Fisher Corporate Information, Head Office, and Major Competitors
    Table 31. Thermo Fisher Major Business
    Table 32. Thermo Fisher Influenza Diagnostics Product and Solutions
    Table 33. Thermo Fisher Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Meridian Bioscience Corporate Information, Head Office, and Major Competitors
    Table 35. Meridian Bioscience Major Business
    Table 36. Meridian Bioscience Influenza Diagnostics Product and Solutions
    Table 37. Meridian Bioscience Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. BioMerieux Corporate Information, Head Office, and Major Competitors
    Table 39. BioMerieux Major Business
    Table 40. BioMerieux Influenza Diagnostics Product and Solutions
    Table 41. BioMerieux Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Sekisui Diagnostics Corporate Information, Head Office, and Major Competitors
    Table 43. Sekisui Diagnostics Major Business
    Table 44. Sekisui Diagnostics Influenza Diagnostics Product and Solutions
    Table 45. Sekisui Diagnostics Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Response Biomedical Corporate Information, Head Office, and Major Competitors
    Table 47. Response Biomedical Major Business
    Table 48. Response Biomedical Influenza Diagnostics Product and Solutions
    Table 49. Response Biomedical Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. SA Scientific Corporate Information, Head Office, and Major Competitors
    Table 51. SA Scientific Major Business
    Table 52. SA Scientific Influenza Diagnostics Product and Solutions
    Table 53. SA Scientific Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Global Influenza Diagnostics Revenue (USD Million) by Players (2019-2021)
    Table 55. Global Influenza Diagnostics Revenue Share by Players (2019-2021)
    Table 56. Breakdown of Influenza Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 57. Influenza Diagnostics Players Head Office, Products and Services Provided
    Table 58. Influenza Diagnostics Mergers & Acquisitions in the Past Five Years
    Table 59. Influenza Diagnostics New Entrants and Expansion Plans
    Table 60. Global Influenza Diagnostics Revenue (USD Million) by Type (2016-2021)
    Table 61. Global Influenza Diagnostics Revenue Share by Type (2016-2021)
    Table 62. Global Influenza Diagnostics Revenue Forecast by Type (2021-2026)
    Table 63. Global Influenza Diagnostics Revenue by Application (2016-2021)
    Table 64. Global Influenza Diagnostics Revenue Forecast by Application (2021-2026)
    Table 65. North America Influenza Diagnostics Revenue by Type (2016-2021) & (USD Million)
    Table 66. North America Influenza Diagnostics Revenue by Type (2021-2026) & (USD Million)
    Table 67. North America Influenza Diagnostics Revenue by Application (2016-2021) & (USD Million)
    Table 68. North America Influenza Diagnostics Revenue by Application (2021-2026) & (USD Million)
    Table 69. North America Influenza Diagnostics Revenue by Country (2016-2021) & (USD Million)
    Table 70. North America Influenza Diagnostics Revenue by Country (2021-2026) & (USD Million)
    Table 71. Europe Influenza Diagnostics Revenue by Type (2016-2021) & (USD Million)
    Table 72. Europe Influenza Diagnostics Revenue by Type (2021-2026) & (USD Million)
    Table 73. Europe Influenza Diagnostics Revenue by Application (2016-2021) & (USD Million)
    Table 74. Europe Influenza Diagnostics Revenue by Application (2021-2026) & (USD Million)
    Table 75. Europe Influenza Diagnostics Revenue by Country (2016-2021) & (USD Million)
    Table 76. Europe Influenza Diagnostics Revenue by Country (2021-2026) & (USD Million)
    Table 77. Asia-Pacific Influenza Diagnostics Revenue by Type (2016-2021) & (USD Million)
    Table 78. Asia-Pacific Influenza Diagnostics Revenue by Type (2021-2026) & (USD Million)
    Table 79. Asia-Pacific Influenza Diagnostics Revenue by Application (2016-2021) & (USD Million)
    Table 80. Asia-Pacific Influenza Diagnostics Revenue by Application (2021-2026) & (USD Million)
    Table 81. Asia-Pacific Influenza Diagnostics Revenue by Region (2016-2021) & (USD Million)
    Table 82. Asia-Pacific Influenza Diagnostics Revenue by Region (2021-2026) & (USD Million)
    Table 83. South America Influenza Diagnostics Revenue by Type (2016-2021) & (USD Million)
    Table 84. South America Influenza Diagnostics Revenue by Type (2021-2026) & (USD Million)
    Table 85. South America Influenza Diagnostics Revenue by Application (2016-2021) & (USD Million)
    Table 86. South America Influenza Diagnostics Revenue by Application (2021-2026) & (USD Million)
    Table 87. South America Influenza Diagnostics Revenue by Country (2016-2021) & (USD Million)
    Table 88. South America Influenza Diagnostics Revenue by Country (2021-2026) & (USD Million)
    Table 89. Middle East & Africa Influenza Diagnostics Revenue by Type (2016-2021) & (USD Million)
    Table 90. Middle East & Africa Influenza Diagnostics Revenue by Type (2021-2026) & (USD Million)
    Table 91. Middle East & Africa Influenza Diagnostics Revenue by Application (2016-2021) & (USD Million)
    Table 92. Middle East & Africa Influenza Diagnostics Revenue by Application (2021-2026) & (USD Million)
    Table 93. Middle East & Africa Influenza Diagnostics Revenue by Country (2016-2021) & (USD Million)
    Table 94. Middle East & Africa Influenza Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Influenza Diagnostics Picture
    Figure 2. Global Influenza Diagnostics Revenue Market Share by Type in 2020
    Figure 3. RIDT
    Figure 4. RT-PCR
    Figure 5. Cell Culture
    Figure 6. Others
    Figure 7. Influenza Diagnostics Revenue Market Share by Application in 2020
    Figure 8. Hospitals Picture
    Figure 9. POCT Picture
    Figure 10. Others Picture
    Figure 11. Global Influenza Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 12. Global Influenza Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
    Figure 13. Global Influenza Diagnostics Revenue Market Share by Region (2016-2026)
    Figure 14. Global Influenza Diagnostics Revenue Market Share by Region in 2020
    Figure 15. North America Influenza Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Europe Influenza Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Asia-Pacific Influenza Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. South America Influenza Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Middle East and Africa Influenza Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. Influenza Diagnostics Market Drivers
    Figure 21. Influenza Diagnostics Market Restraints
    Figure 22. Influenza Diagnostics Market Trends
    Figure 23. BD Recent Developments and Future Plans
    Figure 24. Abbott (Include Alere) Recent Developments and Future Plans
    Figure 25. Roche Recent Developments and Future Plans
    Figure 26. SIEMENS Recent Developments and Future Plans
    Figure 27. Analytik Jena Recent Developments and Future Plans
    Figure 28. Quidel Recent Developments and Future Plans
    Figure 29. Thermo Fisher Recent Developments and Future Plans
    Figure 30. Meridian Bioscience Recent Developments and Future Plans
    Figure 31. BioMerieux Recent Developments and Future Plans
    Figure 32. Sekisui Diagnostics Recent Developments and Future Plans
    Figure 33. Response Biomedical Recent Developments and Future Plans
    Figure 34. SA Scientific Recent Developments and Future Plans
    Figure 35. Global Influenza Diagnostics Revenue Share by Players in 2020
    Figure 36. Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 37. Global Top 3 Players Influenza Diagnostics Revenue Market Share in 2020
    Figure 38. Global Top 10 Players Influenza Diagnostics Revenue Market Share in 2020
    Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 40. Global Influenza Diagnostics Revenue Share by Type in 2020
    Figure 41. Global Influenza Diagnostics Market Share Forecast by Type (2021-2026)
    Figure 42. Global Influenza Diagnostics Revenue Share by Application in 2020
    Figure 43. Global Influenza Diagnostics Market Share Forecast by Application (2021-2026)
    Figure 44. North America Influenza Diagnostics Sales Market Share by Type (2016-2026)
    Figure 45. North America Influenza Diagnostics Sales Market Share by Application (2016-2026)
    Figure 46. North America Influenza Diagnostics Revenue Market Share by Country (2016-2026)
    Figure 47. United States Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. Canada Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Mexico Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Europe Influenza Diagnostics Sales Market Share by Type (2016-2026)
    Figure 51. Europe Influenza Diagnostics Sales Market Share by Application (2016-2026)
    Figure 52. Europe Influenza Diagnostics Revenue Market Share by Country (2016-2026)
    Figure 53. Germany Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. France Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. United Kingdom Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Russia Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Italy Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Asia-Pacific Influenza Diagnostics Sales Market Share by Type (2016-2026)
    Figure 59. Asia-Pacific Influenza Diagnostics Sales Market Share by Application (2016-2026)
    Figure 60. Asia-Pacific Influenza Diagnostics Revenue Market Share by Region (2016-2026)
    Figure 61. China Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Japan Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. South Korea Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. India Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Southeast Asia Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Australia Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. South America Influenza Diagnostics Sales Market Share by Type (2016-2026)
    Figure 68. South America Influenza Diagnostics Sales Market Share by Application (2016-2026)
    Figure 69. South America Influenza Diagnostics Revenue Market Share by Country (2016-2026)
    Figure 70. Brazil Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Argentina Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Middle East and Africa Influenza Diagnostics Sales Market Share by Type (2016-2026)
    Figure 73. Middle East and Africa Influenza Diagnostics Sales Market Share by Application (2016-2026)
    Figure 74. Middle East and Africa Influenza Diagnostics Revenue Market Share by Country (2016-2026)
    Figure 75. Turkey Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Saudi Arabia Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. UAE Influenza Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Methodology
    Figure 79. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

Related Reports

Global Influenza Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Influenza Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Medical Care

The Influenza Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Influenza Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Influenza Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Care

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

Global Influenza Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Influenza Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at USD 2403.1 million in 2023 and is forecast to a readjusted size of USD 3620.3 million by 2030 with a CAGR of 6.0% during review period.

Global Influenza Diagnostics Supply, Demand and Key Producers, 2024-2030

Global Influenza Diagnostics Supply, Demand and Key Producers, 2024-2030

date 08 Feb 2024

date Medical Care

The global Influenza Diagnostics market size is expected to reach $ 3620.3 million by 2030, rising at a market growth of 6.0% CAGR during the forecast period (2024-2030).

Product Tags

influenza diagnostics

general influenza diagnostics

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>